Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

IAVI Report

Coding for protection

November 22, 2019

Although challenges remain, the growing field of mRNA-based vaccine development seems to have a bright future, with potential for preventing cancer, flu, and HIV.

Read more

IAVI Report

Is there an HIV prevention crisis?

November 22, 2019

More HIV-infected people than ever before are receiving life-saving treatment. Despite this progress, HIV incidence rates remain virtually static.

Read more

IAVI Report

Upcoming efficacy trial illustrates the value of African-led science

November 22, 2019

We must continue to engage local investigators and develop their capacity to conduct more basic and clinical research on the African continent.

Read more

IAVI Report

Proven against Ebola, a vector shows its broader potential

November 22, 2019

Regulatory approval of a vesicular stomatitis virus-based vaccine paves the way for use of this viral vector in other vaccines.

Read more

IAVI Report

Turning the tide on TB?

November 22, 2019

A slew of potential advances in treating and preventing tuberculosis offers new hope in the battle against one of the oldest human afflictions.

Read more

IAVI Report

Vaccines: adapting to the times

November 22, 2019

Over hundreds of years, researchers have matched contemporary scientific tools to address the infectious disease threats of their times.

Read more

IAVI Report

Taking the next step with the mosaic HIV vaccine candidate

November 22, 2019

Maria Grazia Pau, senior director, compound development team leader for HIV vaccine programs at the Janssen Pharmaceutical Companies of Johnson & Johnson, talks with IAVI Report about the start of the company’s Phase III Mosaico trial.

Read more

IAVI Report

Could vaccines reach remote areas … remotely?

November 22, 2019

Drone delivery may help overcome the challenge of getting medicines and vaccines to hard-to-reach populations.

Read more